Prov. Artemisa, Cuba

Lena Aguiar García

USPTO Granted Patents = 1 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Lena Aguiar García

Introduction: Lena Aguiar García is a notable inventor from Prov. Artemisa, Cuba, whose research and innovations in the field of cancer treatment are making significant strides. With one patent to her name, García is dedicated to developing advanced pharmaceutical solutions addressing critical health challenges.

Latest Patents: Lena Aguiar García's patent, titled "Ganglioside GM3-containing nanoparticles as immunomodulators," presents a groundbreaking pharmaceutical composition. This innovative invention describes a formulation that includes conjugates of membrane vesicles and the GM3 ganglioside. With specific characteristics related to size, surface charge, and morphology, these nanoparticles showcase advantageous properties as immunomodulators. The patent emphasizes their ability to induce a substantial reduction in myeloid-derived suppressor cells, which positively influences lymphocyte response and the overall survival rates of cancer patients. Moreover, the invention outlines a methodology for treating various cancers, particularly those with high levels of myeloid-derived suppressor cells (MDSCs), and provides a framework for selecting suitable patients for this treatment approach.

Career Highlights: Lena Aguiar García is currently affiliated with the Centro de Inmunología Molecular, a leading institution dedicated to immunological research and innovation. Her work contributes to a deeper understanding of immune responses, particularly in the context of cancer treatment, showcasing her commitment to advancing medical science.

Collaborations: Throughout her career, García has collaborated with esteemed colleagues such as Circe Mesa Pardillo and Liliana Oliver Ríos. These partnerships reflect a collaborative spirit in the research community, enhancing the impact of their discoveries in improving patient outcomes.

Conclusion: Lena Aguiar García's innovative contributions to the field of cancer treatment epitomize the importance of research and development in medical science. Her pioneering work in creating ganglioside GM3-containing nanoparticles as immunomodulators signifies a potential breakthrough in treating cancers associated with myeloid-derived suppressor cells. As research continues, García's inventions will undoubtedly play a vital role in enhancing therapeutic options and improving the lives of patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…